Chung YH - Search Results

1

p16 Hypermethylation in the early stage of hepatitis B virus-associated hepatocarcinogenesis.

Shim YH, Yoon GS, Choi HJ, Chung YH, Yu E. Shim YH, et al. Among authors: chung yh. Cancer Lett. 2003 Feb 20;190(2):213-9. doi: 10.1016/s0304-3835(02)00613-4. Cancer Lett. 2003. PMID: 12565176

2

Four cases of hepatitis B virus-related fibrosing cholestatic hepatitis treated with lamivudine.

Jung S, Lee HC, Han JM, Lee YJ, Chung YH, Lee YS, Kwon Y, Yu E, Suh DJ. Jung S, et al. Among authors: chung yh. J Gastroenterol Hepatol. 2002 Mar;17(3):345-50. doi: 10.1046/j.1440-1746.2002.02600.x. J Gastroenterol Hepatol. 2002. PMID: 11982709

3

Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.

Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI. Park IY, et al. Among authors: chung yh. Gastroenterology. 2007 Apr;132(4):1476-94. doi: 10.1053/j.gastro.2007.01.034. Epub 2007 Jan 25. Gastroenterology. 2007. PMID: 17408664

4

High HBV-DNA titer in surrounding liver rather than in hepatocellular carcinoma tissue predisposes to recurrence after curative surgical resection.

Choi JG, Chung YH, Kim JA, Jin YJ, Park WH, Lee D, Shim JH, Lee YS, Seo DD, Jang MK, Kim KM, Lim YS, Lee HC, Lee YS, Yu E, Lee YJ. Choi JG, et al. Among authors: chung yh. J Clin Gastroenterol. 2012 May-Jun;46(5):413-9. doi: 10.1097/MCG.0b013e3182371285. J Clin Gastroenterol. 2012. PMID: 22105184

5

Safety and efficacy of adjuvant pegylated interferon therapy for metastatic tumor antigen 1-positive hepatocellular carcinoma.

Lee D, Chung YH, Kim JA, Park WH, Jin YJ, Shim JH, Ryu SH, Jang MK, Yu E, Lee YJ. Lee D, et al. Among authors: chung yh. Cancer. 2013 Jun 15;119(12):2239-46. doi: 10.1002/cncr.28082. Epub 2013 Apr 5. Cancer. 2013. PMID: 23564564 Free article. Clinical Trial.

6

Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.

Lee D, Lyu H, Chung YH, Kim JA, Mathews P, Jaffee E, Zheng L, Yu E, Lee YJ, Ryu SH. Lee D, et al. Among authors: chung yh. World J Gastroenterol. 2016 Jun 21;22(23):5393-9. doi: 10.3748/wjg.v22.i23.5393. World J Gastroenterol. 2016. PMID: 27340355 Free PMC article.

7

Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma.

Ryu SH, Chung YH, Lee H, Kim JA, Shin HD, Min HJ, Seo DD, Jang MK, Yu E, Kim KW. Ryu SH, et al. Among authors: chung yh. Hepatology. 2008 Mar;47(3):929-36. doi: 10.1002/hep.22124. Hepatology. 2008. PMID: 18306220

8

Histological characteristics predisposing to development of hepatocellular carcinoma in patients with chronic hepatitis B.

Lee SH, Chung YH, Kim JA, Jin YJ, Park WH, Choi JG, Lee D, Shim JH, Yu E, Jang MK. Lee SH, et al. Among authors: chung yh. J Clin Pathol. 2011 Jul;64(7):599-604. doi: 10.1136/jclinpath-2011-200036. Epub 2011 May 14. J Clin Pathol. 2011. PMID: 21572113

9

Factors predisposing metastatic tumor antigen 1 overexpression in hepatitis B virus associated hepatocellular carcinoma.

Jin YJ, Chung YH, Kim JA, Park WH, Lee D, Seo DD, Ryu SH, Jang MK, Yu E, Lee YJ. Jin YJ, et al. Among authors: chung yh. Dig Dis Sci. 2012 Nov;57(11):2917-23. doi: 10.1007/s10620-012-2296-z. Epub 2012 Jul 10. Dig Dis Sci. 2012. PMID: 22777614

10

Effect of response to interferon-α therapy on the occurrence of hepatocellular carcinoma in patients with chronic hepatitis B.

Lee D, Chung YH, Lee SH, Kim SE, Lee YS, Kim KM, Lim YS, Lee HC, Lee YS, Yu E. Lee D, et al. Among authors: chung yh. Dig Dis. 2012;30(6):568-73. doi: 10.1159/000343068. Epub 2012 Dec 13. Dig Dis. 2012. PMID: 23258096

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

926 results

Search Page

Filters